Milestone Pharmaceuticals announced the FDA approval of prescription etripamil nasal spray for the treatment of acute ...
ReBoost Nasal Spray was recalled after it was "found to contain yeast/mold and microbial contamination," the FDA states, adding, "There is a reasonable probability that adverse health consequences, ...
The self-administered treatment rapidly converts patients into sinus rhythm and may reduce trips to the hospital.
(NEXSTAR) — A New Mexico company has voluntarily recalled one lot of nasal spray sold nationwide after it was found to ...
The voluntary recall of ReBoost Nasal Spray was issued Wednesday by MediNatura New Mexico, according to an announcement from ...
The U.S. Food and Drug Administration has announced a nationwide recall of nasal spray, which officials report has been found ...
The FDA approved Milestone Pharmaceuticals' Cardamyst nasal spray for acute episodes of PSVT in adults. First treatment for ...